Antisense compounds are provided for inhibiting PKB (protein kinase B) alpha, beta and gamma. The antisense compounds display high potency and selectivity. The antisense compounds do not suffer from problems of dimerisation or self-hybridization and have also been selected to not affect other enzymes. The antisense compounds may be used singularly or in combination to inhibit one, two or all of PKB alpha, beta and gamma and hence treat conditions in which these enzymes are important.

 
Web www.patentalert.com

< Process for the preparation of esters of diacerein with hyaluronic acid and pharmaceutical compositions containing such esters

> HEPATITIS C ANTIVIRALS

> Method for chemically modifying polysaccharides

~ 00546